Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study
Description
We surveyed changes in angiotensin-converting enzyme inhibitor (ACEIs) and angiotensin II receptor blocker (ARBs) prescription trends during the coronavirus disease 2019 (COVID-19) pandemic in Japan. Data of 1,605,708 outpatients with hypertension